---
title: "Cortagen"
canonical_url: https://peptidelibrary.app/library/cortagen
description: "Ala-Glu-Asp-Pro, a synthetic tetrapeptide in the Khavinson bioregulator series associated with cerebral cortex tissue. Reported findings concern cortical neuron protein synthesis and nerve regeneration in animal models, published largely in Russian-language journals by a single research group without independent replication. No controlled human evidence exists, and it is not FDA-approved."
updated: 2026-11-07
publisher: Peptide Library
notice: "Research and educational use only. Not medical advice."
---

# Cortagen

Cortagen (also called Brain cortex bioregulator or Ala-Glu-Asp-Pro) is a khavinson cortical bioregulator. Cortagen is Ala-Glu-Asp-Pro, a synthetic tetrapeptide in the Khavinson series associated with cerebral cortex tissue. The mechanism proposed for the series is that short peptides pass into the nucleus and bind specific promoter regions of DNA, altering transcription of genes relevant to the tissue they were derived from.

Ala-Glu-Asp-Pro, a synthetic tetrapeptide in the Khavinson bioregulator series associated with cerebral cortex tissue. Reported findings concern cortical neuron protein synthesis and nerve regeneration in animal models, published largely in Russian-language journals by a single research group without independent replication. No controlled human evidence exists, and it is not FDA-approved.

Also known as: Brain cortex bioregulator, Ala-Glu-Asp-Pro.

Categories: Cognitive, Experimental.

## Classification

- Type: Khavinson cortical bioregulator / research
- Mechanism class: Short Peptide Bioregulator
- Development stage: Research only
- Regulatory class: Research compound, not FDA-approved

## Mechanism

Cortagen is Ala-Glu-Asp-Pro, a synthetic tetrapeptide in the Khavinson series associated with cerebral cortex tissue. The mechanism proposed for the series is that short peptides pass into the nucleus and bind specific promoter regions of DNA, altering transcription of genes relevant to the tissue they were derived from. Reported findings concern cortical neuron protein synthesis and regeneration after nerve injury in animal models. The supporting work is almost entirely cell-culture and cytogenetic research from one group, published in Russian-language journals, without independent replication or any characterised receptor or signalling cascade.

Targets: Cortical neurons (proposed).

Origin: Synthetic short peptide.

## Properties

- Molecular formula: C17H26N4O9
- Molecular weight: 430.4 g/mol
- CAS number: 335591-03-2

## Evidence

- Evidence level: Insufficient Evidence
- Highest documented: Lab & animal studies
- Human trials: 0
- Controlled human trials: 0
- Preclinical sources: 2
- Latest source: 2004

No human dose is established for this compound.

Each step shows whether the sources Peptide Library has reviewed include that kind of research. Counts are reviewed sources, not every study ever published. Reviews and programme summaries that describe human use are shown as "reported", not as trials, and registered trials without published results are listed but not counted. A higher step means research has progressed further; it does not mean a compound works better or is safer. Compounds whose evidence has not been reviewed yet show "Not reviewed" instead of a guess.

### Studies

1. Effect of tetrapeptide cortagen on regeneration of sciatic nerve. Bull Exp Biol Med. 2000. 2000. Preclinical: animal or lab study. Population: Rats after cutting and suturing of the sciatic nerve. Regenerating nerve fibres grew 27% faster and conducted 40% faster. Limitations: Lab or animal research: not evidence of a human effect or dose. [Source](https://pubmed.ncbi.nlm.nih.gov/11276314/)
2. Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray. Neuro Endocrinol Lett. 2004. 2004. Preclinical: animal or lab study. Population: Female CBA mice aged 6 months. 234 heart transcripts (110 known genes) changed expression. Limitations: Lab or animal research: not evidence of a human effect or dose. [Source](https://pubmed.ncbi.nlm.nih.gov/15159690/)

## Safety

Side effects: Not characterized.

Risks: Research-only.

Human safety basis: No controlled human safety data

Key limitations: No established human dosage.; No controlled human trial results in the reviewed sources.; Not approved by the FDA for any use..

## Regulatory status

Cortagen is not an FDA-approved product. It is sold for laboratory research and has no approved medical use.

- FDA status: Not Approved
- Availability: Research-Only

## Frequently asked questions

### What is Cortagen?

Ala-Glu-Asp-Pro, a synthetic tetrapeptide in the Khavinson bioregulator series associated with cerebral cortex tissue. Reported findings concern cortical neuron protein synthesis and nerve regeneration in animal models, published largely in Russian-language journals by a single research group without independent replication. No controlled human evidence exists, and it is not FDA-approved.

### How does Cortagen work?

Cortagen is Ala-Glu-Asp-Pro, a synthetic tetrapeptide in the Khavinson series associated with cerebral cortex tissue. The mechanism proposed for the series is that short peptides pass into the nucleus and bind specific promoter regions of DNA, altering transcription of genes relevant to the tissue they were derived from.

### Is Cortagen FDA approved?

No. Cortagen is not approved by the FDA for any indication and is categorised as research-only. It has not been reviewed for safety or efficacy as a medicine, and published research should be read as investigation rather than established use.

### What peptides are similar to Cortagen?

Compounds most often compared with Cortagen include Bonomarlot, Bronchogen, Cardiogen and Cartalax. They are grouped by shared mechanism or research area rather than by equivalence, and their regulatory status and evidence base differ.

## References

- [\[Cortexin and cortagen as correcting agents in functional and metabolic disorders in the brain in chronic ischemia\] — Eksp Klin Farmakol, 2011](https://pubmed.ncbi.nlm.nih.gov/21476278/)
- [\[Effects of epithalon and cortagene on immunity and hemostasis in neonatally hypophysectomized chicken and old birds\] — Adv Gerontol, 2008](https://pubmed.ncbi.nlm.nih.gov/19432169/)
- [Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray — Neuro Endocrinol Lett, 2004](https://pubmed.ncbi.nlm.nih.gov/15159690/)
- [The delayed effect of cortagen on the restoration of injured nerve function — Dokl Biol Sci, 2002](https://pubmed.ncbi.nlm.nih.gov/12134478/)
- [Effect of tetrapeptide cortagen on regeneration of sciatic nerve — Bull Exp Biol Med, 2000](https://pubmed.ncbi.nlm.nih.gov/11276314/)
